ENTASIS THERAPEUTICS HLDGS I's ticker is ETTX and the CUSIP is 293614103.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,000 | -33.3% | 1,125 | -30.3% | 0.00% | – |
| Q1 2022 | $3,000 | 0.0% | 1,614 | 0.0% | 0.00% | – |
| Q4 2021 | $3,000 | -40.0% | 1,614 | +0.1% | 0.00% | – |
| Q3 2021 | $5,000 | +25.0% | 1,613 | +2.5% | 0.00% | – |
| Q2 2021 | $4,000 | -42.9% | 1,574 | -55.9% | 0.00% | – |
| Q1 2021 | $7,000 | -22.2% | 3,571 | +0.1% | 0.00% | – |
| Q4 2020 | $9,000 | -18.2% | 3,569 | -35.9% | 0.00% | – |
| Q3 2020 | $11,000 | -31.2% | 5,569 | +1.0% | 0.00% | – |
| Q2 2020 | $16,000 | -23.8% | 5,516 | -31.2% | 0.00% | – |
| Q1 2020 | $21,000 | -55.3% | 8,016 | -15.6% | 0.00% | – |
| Q4 2019 | $47,000 | -13.0% | 9,500 | +5.6% | 0.00% | – |
| Q3 2019 | $54,000 | +20.0% | 9,000 | +28.6% | 0.00% | – |
| Q2 2019 | $45,000 | +2.3% | 7,000 | +7.7% | 0.00% | – |
| Q1 2019 | $44,000 | +83.3% | 6,500 | +8.3% | 0.00% | – |
| Q4 2018 | $24,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,349,953 | $8,046,000 | 2.52% |
| Novo Holdings A/S | 2,181,843 | $13,004,000 | 2.23% |
| Sofinnova Investments, Inc. | 1,180,178 | $7,034,000 | 0.64% |
| TPG Group Holdings (SBS) Advisors, Inc. | 2,041,496 | $12,168,000 | 0.09% |
| Eventide Asset Management | 392,513 | $2,288,000 | 0.08% |
| Blackstone Inc. | 1,623,405 | $9,675,000 | 0.06% |
| Granahan Investment Management | 141,012 | $840,000 | 0.05% |
| Janney Montgomery Scott LLC | 46,861 | $279,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 5,921 | $35,000 | 0.00% |
| BlackRock Inc. | 15,755 | $94,000 | 0.00% |